The relative roles of each component of the glucose (G)/insulin (I) system in determining after meal hyperglycemia in type 1 diabetes (T1DM) are still under debate. Metabolic Control Analysis (MCA) quantifies the control exerted by each component of a system on a variable of interest, by computing the relevant coefficients of control (CCs), which are systemic properties. We applied MCA to a mixed meal test (MMT) to quantify the CCs of the main components of the G/I system on G concentration. 7 T1DM patients (age: 41±5 yrs; BMI: 24.3±0.6 kg.m-2; HbA1c: 7.9±0.2%) on insulin pump therapy and continuous glucose monitoring (CGM) participated in 2 separate studies:1. A standard euglycemic insulin (240 pmol.min-1.m-2 BSA) clamp (duration: 120 min, M value: 1209±169 µmol.min-1.m-2 BSA) including CGM; 2. A standardized MMT (292 Kcal; 38.9 g complex CHO, 8.9 g lipids, 14 g proteins) with plasma I/G monitoring and CGM. With our modeling strategy, data from the clamp and from the MMT are sufficient to build an in silico replica (“virtual patient”) of the G/I system of each patient (CGM included), which behaves as the real patient during the MMT. Virtual patients were used to compute the CCs of plasma G and G measured by CGM. During the MMT, plasma glucose and insulin peaked at (time ) and at (time ), respectively, and leveled at and at time 300’. The CCs exerted by some primary components of the G/I system on plasma G are summarized in the Table. Size of s.c. insulin depot had the highest CCs (p<0.01 or less vs other CCs). The CCs of meal insulin bolus peaked at 300’ (p<0.01 vs CCs at 30’-60’). The CCs of CHO transit time across the gut, including also absorption, was relevant in the first half and became negligible in the second half of the meal (p<0.01 CCs 180-300’ vs CCs 30’-120’). The CCs of CGM measured G were parallel, but not superimposable to CCs of plasma G, with some statistically significant difference (p<0.03-0.01) in CCs exerted by gut CHO transit time. Conclusions. In patients with T1DM on insulin pump therapy, after a mixed meal: 1. the most relevant factor of after meal G may be the size of subcutaneous insulin depot; 2. Pre-meal insulin bolus may be much more influential in the last 3 than in the initial 2 hours. These findings may have important implications for the development and the refinement of closed loop control of insulin delivery systems.

Quantitation of the roles played by the main determinants of meal glucose tolerance in patients with type 1 diabetes on insulin pump therapy

TROMBETTA, Maddalena;BOSELLI, Maria Linda;DAURIZ, Marco;BONORA, Enzo;BONADONNA, Riccardo
2013-01-01

Abstract

The relative roles of each component of the glucose (G)/insulin (I) system in determining after meal hyperglycemia in type 1 diabetes (T1DM) are still under debate. Metabolic Control Analysis (MCA) quantifies the control exerted by each component of a system on a variable of interest, by computing the relevant coefficients of control (CCs), which are systemic properties. We applied MCA to a mixed meal test (MMT) to quantify the CCs of the main components of the G/I system on G concentration. 7 T1DM patients (age: 41±5 yrs; BMI: 24.3±0.6 kg.m-2; HbA1c: 7.9±0.2%) on insulin pump therapy and continuous glucose monitoring (CGM) participated in 2 separate studies:1. A standard euglycemic insulin (240 pmol.min-1.m-2 BSA) clamp (duration: 120 min, M value: 1209±169 µmol.min-1.m-2 BSA) including CGM; 2. A standardized MMT (292 Kcal; 38.9 g complex CHO, 8.9 g lipids, 14 g proteins) with plasma I/G monitoring and CGM. With our modeling strategy, data from the clamp and from the MMT are sufficient to build an in silico replica (“virtual patient”) of the G/I system of each patient (CGM included), which behaves as the real patient during the MMT. Virtual patients were used to compute the CCs of plasma G and G measured by CGM. During the MMT, plasma glucose and insulin peaked at (time ) and at (time ), respectively, and leveled at and at time 300’. The CCs exerted by some primary components of the G/I system on plasma G are summarized in the Table. Size of s.c. insulin depot had the highest CCs (p<0.01 or less vs other CCs). The CCs of meal insulin bolus peaked at 300’ (p<0.01 vs CCs at 30’-60’). The CCs of CHO transit time across the gut, including also absorption, was relevant in the first half and became negligible in the second half of the meal (p<0.01 CCs 180-300’ vs CCs 30’-120’). The CCs of CGM measured G were parallel, but not superimposable to CCs of plasma G, with some statistically significant difference (p<0.03-0.01) in CCs exerted by gut CHO transit time. Conclusions. In patients with T1DM on insulin pump therapy, after a mixed meal: 1. the most relevant factor of after meal G may be the size of subcutaneous insulin depot; 2. Pre-meal insulin bolus may be much more influential in the last 3 than in the initial 2 hours. These findings may have important implications for the development and the refinement of closed loop control of insulin delivery systems.
2013
type 1 diabetes; pump insulin
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/870216
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact